Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for preoperative weight loss in bariatric surgery
NCT06201819Phase 4Completed
- Sponsor
- Unidad de Cirugía Bariátrica, Hospital Civil Dr. Juan I. Menchaca
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liraglutide in obesity, sponsored by Unidad de Cirugía Bariátrica, Hospital Civil Dr. Juan I. Menchaca. Primary endpoint: Preoperative weight changes at 3 months. Started Dec 2022; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06201819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06201819.